Hodgkin's disease in children

Hematol Oncol Clin North Am. 1989 Jun;3(2):345-65.

Abstract

This article discusses the presentation and evolution of therapy of pediatric Hodgkin's disease, contrasted with developments in adults. The issues of staging, treatment, and toxicity of radiotherapy, chemotherapy, and combined modality therapy are discussed. Recommendations for therapy are presented.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Age Factors
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Child
  • Child, Preschool
  • Combined Modality Therapy / adverse effects
  • Europe
  • Female
  • Growth Disorders / etiology
  • Hodgkin Disease / epidemiology
  • Hodgkin Disease / pathology
  • Hodgkin Disease / therapy*
  • Humans
  • Hypothyroidism / etiology
  • Male
  • Neoplasm Staging
  • Neoplasms, Multiple Primary / etiology
  • Radiotherapy / adverse effects
  • Sex Factors
  • Splenectomy / adverse effects
  • United States